JP2010501598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501598A5 JP2010501598A5 JP2009525881A JP2009525881A JP2010501598A5 JP 2010501598 A5 JP2010501598 A5 JP 2010501598A5 JP 2009525881 A JP2009525881 A JP 2009525881A JP 2009525881 A JP2009525881 A JP 2009525881A JP 2010501598 A5 JP2010501598 A5 JP 2010501598A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- disease
- nhch
- interfering substituent
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C[C@]1OC2SC(*)=NC2[C@@](*)[C@@]1O Chemical compound *C[C@]1OC2SC(*)=NC2[C@@](*)[C@@]1O 0.000 description 2
- SJOFQKYWIQVOLP-QJVVIPRHSA-N CCNC(SC(CC12)OC(C3)(C3O)[C@H]3O)=N[C@H]1C2C3O Chemical compound CCNC(SC(CC12)OC(C3)(C3O)[C@H]3O)=N[C@H]1C2C3O SJOFQKYWIQVOLP-QJVVIPRHSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84119606P | 2006-08-31 | 2006-08-31 | |
| US60/841,196 | 2006-08-31 | ||
| US89566307P | 2007-03-19 | 2007-03-19 | |
| US60/895,663 | 2007-03-19 | ||
| PCT/CA2007/001554 WO2008025170A1 (en) | 2006-08-31 | 2007-08-31 | Selective glycosidase inhibitors and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013123917A Division JP5771237B2 (ja) | 2006-08-31 | 2013-06-12 | 選択的グリコシダーゼ阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501598A JP2010501598A (ja) | 2010-01-21 |
| JP2010501598A5 true JP2010501598A5 (enExample) | 2010-10-21 |
| JP5380293B2 JP5380293B2 (ja) | 2014-01-08 |
Family
ID=39135489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525881A Expired - Fee Related JP5380293B2 (ja) | 2006-08-31 | 2007-08-31 | 選択的グリコシダーゼ阻害剤およびその使用 |
| JP2013123917A Expired - Fee Related JP5771237B2 (ja) | 2006-08-31 | 2013-06-12 | 選択的グリコシダーゼ阻害剤およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013123917A Expired - Fee Related JP5771237B2 (ja) | 2006-08-31 | 2013-06-12 | 選択的グリコシダーゼ阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8334310B2 (enExample) |
| EP (2) | EP2057171A4 (enExample) |
| JP (2) | JP5380293B2 (enExample) |
| AU (1) | AU2007291870B2 (enExample) |
| CA (1) | CA2661582C (enExample) |
| WO (1) | WO2008025170A1 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006220187B2 (en) * | 2005-03-01 | 2012-11-08 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| EP2057171A4 (en) | 2006-08-31 | 2010-04-21 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF |
| EP2321289A4 (en) * | 2008-08-01 | 2011-11-16 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE HEMMER AND ITS USE |
| CA2732335A1 (en) | 2008-08-01 | 2010-02-04 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| US9120781B2 (en) | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| WO2012014786A1 (en) * | 2010-07-30 | 2012-02-02 | Semiconductor Energy Laboratory Co., Ltd. | Semicondcutor device and manufacturing method thereof |
| TW201249848A (en) | 2010-11-08 | 2012-12-16 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
| US8933040B2 (en) | 2010-11-08 | 2015-01-13 | Craig A. Coburn | Selective glycosidase inhibitors and uses thereof |
| US8901087B2 (en) | 2010-11-08 | 2014-12-02 | Merck Sharp & Dohme Corp. | Selective glycosidase inhibitors and uses thereof |
| WO2012061972A1 (en) * | 2010-11-08 | 2012-05-18 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| DK2655388T3 (en) * | 2010-12-23 | 2016-09-19 | Alectos Therapeutics Inc | Selective glykosidaseinhibitorer and uses thereof |
| WO2012126091A1 (en) * | 2011-03-24 | 2012-09-27 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2012129802A1 (en) * | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Pyrano[3,2-d]thiazol derivatives and uses as selective glycosidase inhibitors thereof |
| WO2012129651A1 (en) * | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2013000086A1 (en) * | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2013000085A1 (en) | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| CN103889996B (zh) * | 2011-06-27 | 2016-02-03 | 阿列科托斯治疗有限公司 | 选择性糖苷酶抑制剂及其用途 |
| EP2744338B1 (en) * | 2011-08-18 | 2016-04-27 | Merck Sharp & Dohme Corp. | Selective glycosidase inhibitors and uses thereof |
| AU2012298949B2 (en) * | 2011-08-25 | 2016-09-22 | Merck Patent Gmbh | Pyrano [3, 2 - D] [1, 3] thiazole as glycosidase inhibitors |
| US9603907B2 (en) | 2012-02-01 | 2017-03-28 | Protalix Ltd. | Dry powder formulations of dNase I |
| KR102108586B1 (ko) * | 2012-05-08 | 2020-05-07 | 머크 샤프 앤드 돔 코포레이션 | 투과성 글리코시다제 억제제 및 그의 용도 |
| WO2013166654A1 (en) * | 2012-05-08 | 2013-11-14 | Merck Sharp & Dohme Corp. | Permeable glycosidase inhibitors and uses thereof |
| WO2014032185A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2014032188A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2014067003A1 (en) * | 2012-10-31 | 2014-05-08 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2014100934A1 (en) | 2012-12-24 | 2014-07-03 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| US20160017021A1 (en) | 2013-03-06 | 2016-01-21 | Protalix Ltd. | TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME |
| PT2970272T (pt) | 2013-03-14 | 2019-06-05 | Merck Patent Gmbh | Inibidores de glicosidase |
| US9598438B2 (en) * | 2014-02-12 | 2017-03-21 | Amicus Therapeutics, Inc. | Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC |
| US10899784B2 (en) | 2014-08-15 | 2021-01-26 | The Johns Hopkins University | Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway |
| EP3868752A1 (en) | 2014-08-28 | 2021-08-25 | Asceneuron SA | Glycosidase inhibitors |
| JPWO2016056204A1 (ja) * | 2014-10-10 | 2017-07-13 | 株式会社Ｊｏｌｅｄ | 薄膜トランジスタ基板、薄膜トランジスタ基板の製造方法、及び、表示パネル |
| WO2016207245A1 (en) | 2015-06-24 | 2016-12-29 | F. Hoffmann-La Roche Ag | Humanized anti-tau(ps422) antibodies and methods of use |
| WO2018153508A2 (en) | 2017-02-24 | 2018-08-30 | Asceneuron S.A. | Sulfoximine glycosidase inhibitors |
| US11261183B2 (en) | 2016-02-25 | 2022-03-01 | Asceneuron Sa | Sulfoximine glycosidase inhibitors |
| SG11201807012QA (en) | 2016-02-25 | 2018-09-27 | Asceneuron S A | Acid addition salts of piperazine derivatives |
| AU2017222958B2 (en) | 2016-02-25 | 2019-07-18 | Asceneuron S. A. | Glycosidase inhibitors |
| CN108884078A (zh) | 2016-02-25 | 2018-11-23 | 阿森纽荣股份公司 | 糖苷酶抑制剂 |
| WO2019037860A1 (en) | 2017-08-24 | 2019-02-28 | Asceneuron S.A. | LINEAR INHIBITORS OF GLYCOSIDASE |
| WO2019037861A1 (en) | 2017-08-24 | 2019-02-28 | Asceneuron S.A. | ANNOTATED GLYCOSIDASE INHIBITORS |
| WO2020039027A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Pyrrolidine glycosidase inhibitors |
| WO2020039029A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Spiro compounds as glycosidase inhibitors |
| WO2020039028A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Tetrahydro-benzoazepine glycosidase inhibitors |
| IL280841B2 (en) | 2018-08-22 | 2024-12-01 | Asceneuron S A | Succinate and fumarate acid addition salts of piperazine derivatives useful as glycosidase inhibitors |
| US20220143042A1 (en) | 2019-02-22 | 2022-05-12 | Asceneuron Sa | Fused glycosidase inhibitors |
| AU2021455177B2 (en) | 2021-07-05 | 2025-01-09 | Asceneuron Sa | Medicaments comprising glycosidase inhibitors |
| WO2024083820A1 (en) | 2022-10-18 | 2024-04-25 | Institut National de la Santé et de la Recherche Médicale | Method and composition for determining the level of o-glcnacylation in horses |
| WO2025131275A1 (en) | 2023-12-20 | 2025-06-26 | Asceneuron Sa | (2-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperazin-1 -yl)pyrimidin-5-yl)(imino)(methyl)-lamda6-sulfanone for use in the treatment of colitis, parkinson disease, tauopathy, als and alzheimer's disease |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS423200Y1 (enExample) | 1964-02-21 | 1967-02-24 | ||
| JPH01180894A (ja) | 1988-01-07 | 1989-07-18 | Wako Pure Chem Ind Ltd | アミノ糖誘導体の新規な製造法 |
| JPH023200A (ja) | 1988-06-10 | 1990-01-08 | Mitsubishi Electric Corp | 半導体集積回路装置のテスト回路 |
| JPH07316178A (ja) | 1994-05-25 | 1995-12-05 | Sankyo Co Ltd | 糖アミノオキサゾリン類 |
| JPH09132585A (ja) | 1995-11-10 | 1997-05-20 | Shin Etsu Chem Co Ltd | 新規アミノ糖及びキトオリゴ糖又はその類似オリゴ糖の製造方法 |
| WO2000068194A1 (en) | 1999-05-11 | 2000-11-16 | The Scripps Research Institute | Iminocyclitol inhibitors of hexoaminidase and glycosidase |
| US6774140B1 (en) * | 1999-05-11 | 2004-08-10 | The Scripps Research Institute | Iminocyclitol inhibitors of hexoaminidase and glycosidase |
| WO2002072860A1 (en) | 2001-03-14 | 2002-09-19 | Denki Kagaku Kogyo Kabushiki Kaisha | Process for producing hyaluronic acid or its derivative |
| JP4233262B2 (ja) | 2001-03-14 | 2009-03-04 | 生化学工業株式会社 | カルバ糖アミン誘導体及びそれを用いるグリコシダーゼ阻害剤 |
| JP4866515B2 (ja) | 2001-07-02 | 2012-02-01 | 生化学工業株式会社 | 糖オキサゾリン誘導体の製造方法 |
| EP1633356A1 (en) | 2003-05-22 | 2006-03-15 | The Hospital for Sick Children | Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| CN1548053A (zh) | 2003-05-23 | 2004-11-24 | 华晶基因技术有限公司 | 黄芩甙作为治疗焦虑症的药物的新用途 |
| CA2553866A1 (en) | 2004-01-20 | 2005-08-11 | The Scripps Research Institute | Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors |
| US20080166323A1 (en) | 2004-04-14 | 2008-07-10 | Uab Research Foundation | Activators of Hexosamine Biosynthesis as Inhibitors of Injury Induced by Ischemia or Hermorrhagic Shock |
| AU2006220187B2 (en) | 2005-03-01 | 2012-11-08 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| EP2057171A4 (en) | 2006-08-31 | 2010-04-21 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF |
| EP2321289A4 (en) | 2008-08-01 | 2011-11-16 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE HEMMER AND ITS USE |
| CA2732335A1 (en) | 2008-08-01 | 2010-02-04 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| CA2737267A1 (en) | 2008-09-16 | 2010-04-08 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| US9120781B2 (en) | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| US8933040B2 (en) | 2010-11-08 | 2015-01-13 | Craig A. Coburn | Selective glycosidase inhibitors and uses thereof |
| WO2012061972A1 (en) | 2010-11-08 | 2012-05-18 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2012061971A1 (en) | 2010-11-08 | 2012-05-18 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| DK2655388T3 (en) | 2010-12-23 | 2016-09-19 | Alectos Therapeutics Inc | Selective glykosidaseinhibitorer and uses thereof |
| WO2012126091A1 (en) | 2011-03-24 | 2012-09-27 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2012129651A1 (en) | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2013000086A1 (en) | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| CN103889996B (zh) | 2011-06-27 | 2016-02-03 | 阿列科托斯治疗有限公司 | 选择性糖苷酶抑制剂及其用途 |
| WO2013000085A1 (en) | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
-
2007
- 2007-08-31 EP EP07800577A patent/EP2057171A4/en not_active Withdrawn
- 2007-08-31 AU AU2007291870A patent/AU2007291870B2/en not_active Ceased
- 2007-08-31 US US12/438,882 patent/US8334310B2/en not_active Expired - Fee Related
- 2007-08-31 CA CA2661582A patent/CA2661582C/en not_active Expired - Fee Related
- 2007-08-31 EP EP11157096.6A patent/EP2322529B1/en not_active Not-in-force
- 2007-08-31 WO PCT/CA2007/001554 patent/WO2008025170A1/en not_active Ceased
- 2007-08-31 JP JP2009525881A patent/JP5380293B2/ja not_active Expired - Fee Related
-
2012
- 2012-08-22 US US13/591,927 patent/US8962664B2/en not_active Expired - Fee Related
-
2013
- 2013-06-12 JP JP2013123917A patent/JP5771237B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501598A5 (enExample) | ||
| WO2008025170B1 (en) | Selective glycosidase inhibitors and uses thereof | |
| JP2014524911A5 (enExample) | ||
| RU2014102232A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| JP2013541596A5 (enExample) | ||
| JP2011529858A5 (enExample) | ||
| JP2015534991A5 (enExample) | ||
| JP2011529857A5 (enExample) | ||
| RU2013134345A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| JP2012502884A5 (enExample) | ||
| JP5551708B2 (ja) | アゼピノ［４，５−ｂ］インドール化合物およびその使用方法 | |
| KR102108586B1 (ko) | 투과성 글리코시다제 억제제 및 그의 용도 | |
| RU2015120556A (ru) | Ингибиторы гликозидаз и их применения | |
| TWI781177B (zh) | 作為C5a抑制劑之6-5稠合環 | |
| CN105143221A (zh) | 用于治疗炎性障碍的化合物及其药物组合物 | |
| RU2013126531A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| US10836759B2 (en) | Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer | |
| JP2018537483A (ja) | ビアリールモノバクタム化合物および細菌感染治療のためのそれの使用方法 | |
| JP2011524867A (ja) | 糖質コルチコイド模倣物質、その製造方法、医薬組成物、及びその使用 | |
| TW202024073A (zh) | 作為jak抑制劑之二甲基胺基氮雜環丁烷醯胺 | |
| TW202024075A (zh) | 作為jak抑制劑之5至7員雜環醯胺 | |
| US20210138092A1 (en) | Selective ligands for tau aggregates | |
| US9464103B2 (en) | Spirocyclic sulfones as gamma secretase inhibitors | |
| TWI718197B (zh) | 4H-吡唑並[1,5-α]苯並咪唑類化合物晶型及其製備方法和中間體 | |
| EP2387565B1 (en) | 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |